DAWN vs EIX · rev $131.2M vs P/E 7.3, rev $17.60B
Day One Biopharmaceuticals Inc (DAWN) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
DAWN currently screens at market cap $656.8M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the DAWN and EIX stock pages for the full models.
Not investment advice.